Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Spinal Cord Stimulation (SCS) Devices Market by Type (Rechargeable SCS, Non-Rechargeable SCS), By Application (Hospitals, Ambulatory Surgery Centers) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Spinal Cord Stimulation (SCS) Devices Market by Type (Rechargeable SCS, Non-Rechargeable SCS), By Application (Hospitals, Ambulatory Surgery Centers) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 332776 4200 Medical Devices & Consumables 377 240 Pages 4.9 (45)
                                          

Market Overview:


The global spinal cord stimulation (SCS) devices market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic pain, technological advancements in SCS devices, and rising demand for minimally invasive surgeries. Based on type, the global spinal cord stimulation (SCS) devices market is segmented into rechargeable SCS and non-rechargeable SCS. The rechargeable SCS segment is expected to grow at a higher CAGR than the non-rechargeable SCS segment during the forecast period from 2018 to 2030. This growth can be attributed to the increasing preference for rechargeable over non-rechargeable devices among patients and healthcare providers due to various benefits such as longer battery life and lower replacement costs offered by rechargeable devices. Based on application, the global spinal cord stimulation (SCS)devices market is divided into hospitals and ambulatory surgery centers (ASCs). The hospitals segment dominates this market owingtothe high prevalence of chronic pain conditions among hospitalized patientsandthe growing demand for minimally invasive surgeriesin these settings.


Global Spinal Cord Stimulation (SCS) Devices Industry Outlook


Product Definition:


Spinal cord stimulation (SCS) devices are implantable medical devices that send electrical impulses to the spinal cord in an effort to block pain signals from traveling to the brain. SCS devices are often used to treat chronic pain conditions such as back pain, neck pain, and leg pain.


Rechargeable SCS:


Rechargeable SCS (RSS) is a class II medical device used for the treatment of chronic pain. It generates low-frequency electrical stimulation to nerve fibers in the spinal cord, which reduces or eliminates pain. The National Institute of Neurological Disorders and Stroke provides information on research related to neuropathic pain, including studies that use RSS as an effective therapy.


Non-Rechargeable SCS:


Non-rechargeable stimulation systems are used in spinal cord stimulation devices. They are implanted in the patient and can be programmed to provide electrical brain and spinal cord stimulations. These systems have a battery that needs to be replaced after it has lost its capacity or when it is empty (depleted) so that the device can continue working for a while longer.


Application Insights:


Based on application, the global spinal cord stimulation (SCS) devices market is segmented into hospitals and ambulatory surgery centers. The hospitals segment dominated the overall market in 2017 owing to factors such as a high prevalence of neurological disorders that require surgical intervention and an increase in government funding for research pertaining to SCS. In addition, a rise in hospital admissions for chronic pain due to neurological conditions is also expected to drive demand over the forecast period.


The ambulatory surgery centers (ASCs) segment are anticipated to exhibit significant growth over the forecast period owingASCs have lower costs than hospitals and can be located anywhere there is a patient population who needs medical care but cannot afford it or travel far from home. Increasing awareness about ASCs due largely their low cost compared with that of hospitals has led many patients with neurovascular diseases, orthopedic problems or cancer pain seek treatment at these centers which further supports growth prospects of this segment.


Regional Analysis:


North America dominated the global market in 2017. The growth can be attributed to the presence of a large number of manufacturers and distributors, high healthcare expenditure, favorable reimbursement policies for innovations in devices and therapies, and increasing demand for minimally invasive surgeries. In addition, growing awareness about spinal cord stimulation therapy is expected to drive regional growth over the forecast period.


Asia Pacific is expected to witness lucrative CAGR during the forecast period owing to factors such as improving healthcare infrastructure & availability of treatments at affordable costs; rising patient awareness regarding available treatment options; continuous efforts by key players for commercialization of their products at reduced prices; and expansion of distribution channels by international companies. Increasing cases diagnosed with neurodegenerative diseases such as Parkinson’s disease are also contributing toward regional growth.


Growth Factors:


  • Increasing incidence of chronic pain: The global prevalence of chronic pain is estimated to be around 20%. This number is expected to grow in the coming years due to the increasing aging population and rising rates of lifestyle-related diseases. SCS devices are an effective treatment for chronic pain and are thus expected to see high demand in the coming years.
  • Growing awareness about SCS devices: There is a growing awareness among people about the benefits of SCS devices for treating various types of chronic pain. This is helping to drive demand for these devices worldwide.
  • Technological advancements: The technology behind SCS devices is constantly evolving, with new and improved models being launched every year. This helps keep these devices up-to-date with the latest trends and drives their adoption by patients and healthcare providers alike.
  • Rising healthcare expenditure: Globally, healthcare expenditure is on the rise as more people become aware of available treatments and seek better care options for themselves and their loved ones . This trend is benefiting the SCS device market as well, as more people opt for these Devices as a treatment option .

Scope Of The Report

Report Attributes

Report Details

Report Title

Spinal Cord Stimulation (SCS) Devices Market Research Report

By Type

Rechargeable SCS, Non-Rechargeable SCS

By Application

Hospitals, Ambulatory Surgery Centers

By Companies

Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro, Nuvectra

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

240

Number of Tables & Figures

168

Customization Available

Yes, the report can be customized as per your need.


Global Spinal Cord Stimulation (SCS) Devices Market Report Segments:

The global Spinal Cord Stimulation (SCS) Devices market is segmented on the basis of:

Types

Rechargeable SCS, Non-Rechargeable SCS

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Ambulatory Surgery Centers

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Medtronic
  2. Boston Scientific
  3. Abbott (St. Jude Medical)
  4. Nevro
  5. Nuvectra

Global Spinal Cord Stimulation (SCS) Devices Market Overview


Highlights of The Spinal Cord Stimulation (SCS) Devices Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Rechargeable SCS
    2. Non-Rechargeable SCS
  1. By Application:

    1. Hospitals
    2. Ambulatory Surgery Centers
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Spinal Cord Stimulation (SCS) Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Spinal Cord Stimulation (SCS) Devices Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Spinal cord stimulation (SCS) devices are medical devices that use electrical stimulation to treat conditions such as chronic pain, spasticity, and neuropathic pain. SCS is a form of neuromodulation therapy that uses low-level electrical currents to modulate nerve cells in the spinal cord.

Some of the major players in the spinal cord stimulation (scs) devices market are Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro, Nuvectra.

The spinal cord stimulation (scs) devices market is expected to grow at a compound annual growth rate of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Spinal Cord Stimulation (SCS) Devices Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Spinal Cord Stimulation (SCS) Devices Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Spinal Cord Stimulation (SCS) Devices Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Spinal Cord Stimulation (SCS) Devices Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Spinal Cord Stimulation (SCS) Devices Market Size & Forecast, 2020-2028       4.5.1 Spinal Cord Stimulation (SCS) Devices Market Size and Y-o-Y Growth       4.5.2 Spinal Cord Stimulation (SCS) Devices Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Rechargeable SCS
      5.2.2 Non-Rechargeable SCS
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospitals
      6.2.2 Ambulatory Surgery Centers
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Spinal Cord Stimulation (SCS) Devices Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Spinal Cord Stimulation (SCS) Devices Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Rechargeable SCS
      9.6.2 Non-Rechargeable SCS
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospitals
      9.10.2 Ambulatory Surgery Centers
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Rechargeable SCS
      10.6.2 Non-Rechargeable SCS
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospitals
      10.10.2 Ambulatory Surgery Centers
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Rechargeable SCS
      11.6.2 Non-Rechargeable SCS
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospitals
      11.10.2 Ambulatory Surgery Centers
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Rechargeable SCS
      12.6.2 Non-Rechargeable SCS
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospitals
      12.10.2 Ambulatory Surgery Centers
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Rechargeable SCS
      13.6.2 Non-Rechargeable SCS
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospitals
      13.10.2 Ambulatory Surgery Centers
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Spinal Cord Stimulation (SCS) Devices Market: Competitive Dashboard
   14.2 Global Spinal Cord Stimulation (SCS) Devices Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Medtronic
      14.3.2 Boston Scientific
      14.3.3 Abbott (St. Jude Medical)
      14.3.4 Nevro
      14.3.5 Nuvectra

Our Trusted Clients

Contact Us